Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Delft Instruments was a prominent Dutch healthcare and defense technology conglomerate, best known for its innovations in medical imaging and diagnostic systems. The company was established in 1990 through the merger of Oldelft and Enraf-Nonius, creating a powerhouse in X-ray, ultrasound, and radiotherapy technology. Its medical division played a crucial role in global health, particularly through the development of automated tuberculosis screening tools and specialized ultrasound transducers. Following its acquisition by Bencis Capital Partners in 2007, the company was restructured, leading to the emergence of specialized successors like Delft Imaging and Oldelft Ultrasound. Today, its legacy continues through advanced AI-driven diagnostic software used extensively in low-resource settings for infectious disease screening.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Delft Instruments.